Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Levy

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology Bulletin|October 1, 1980
Human memory and the effects of physostigmine and choline chloride [proceedings]K L Davis, R C Mohs, B M Davis, et al.
Biological Psychiatry|December 1, 1983
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normalsS I Deutsch, R C Mohs, M I Levy, et al.
The American Journal of Psychiatry|July 1, 1984
Age and the dexamethasone suppression test in depressionK L Davis, B M Davis, A A Mathé, et al.
Archives of General Psychiatry|May 1, 1984
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responsesM I Levy, B M Davis, R C Mohs, et al.
Archives of General Psychiatry|March 1, 1985
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problemsB M Davis, K L Davis, R C Mohs, et al.
Psychopharmacology Bulletin|January 1, 1983
Oral physostigmine in Alzheimer's diseaseK L Davis, R C Mohs, B M Davis, et al.
Journal of Clinical Psychopharmacology|June 1, 1983
Antipsychotic efficacy of fluotracen: a clinical trialM I Levy, K S Kendler, A A Mathé, et al.
Psychopharmacology Bulletin|January 1, 1984
Apomorphine and schizophreniaC A Johns, M I Levy, B M Davis, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology Bulletin|October 1, 1980
Human memory and the effects of physostigmine and choline chloride [proceedings]K L Davis, R C Mohs, B M Davis, et al.
Biological Psychiatry|December 1, 1983
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normalsS I Deutsch, R C Mohs, M I Levy, et al.
The American Journal of Psychiatry|July 1, 1984
Age and the dexamethasone suppression test in depressionK L Davis, B M Davis, A A Mathé, et al.
Archives of General Psychiatry|May 1, 1984
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responsesM I Levy, B M Davis, R C Mohs, et al.
Archives of General Psychiatry|March 1, 1985
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problemsB M Davis, K L Davis, R C Mohs, et al.
Psychopharmacology Bulletin|January 1, 1983
Oral physostigmine in Alzheimer's diseaseK L Davis, R C Mohs, B M Davis, et al.
Journal of Clinical Psychopharmacology|June 1, 1983
Antipsychotic efficacy of fluotracen: a clinical trialM I Levy, K S Kendler, A A Mathé, et al.
Psychopharmacology Bulletin|January 1, 1984
Apomorphine and schizophreniaC A Johns, M I Levy, B M Davis, et al.
Pageof 2